BR9813985A - Derivados de oxazolidinona e composições farmacêuticas - Google Patents

Derivados de oxazolidinona e composições farmacêuticas

Info

Publication number
BR9813985A
BR9813985A BR9813985-1A BR9813985A BR9813985A BR 9813985 A BR9813985 A BR 9813985A BR 9813985 A BR9813985 A BR 9813985A BR 9813985 A BR9813985 A BR 9813985A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
oxazolidinone derivatives
organisms
oxazolidinone
anaerobic
Prior art date
Application number
BR9813985-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9813985A publication Critical patent/BR9813985A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9813985-1A 1997-11-12 1998-10-30 Derivados de oxazolidinona e composições farmacêuticas BR9813985A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BR9813985A true BR9813985A (pt) 2000-09-26

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813985-1A BR9813985A (pt) 1997-11-12 1998-10-30 Derivados de oxazolidinona e composições farmacêuticas

Country Status (21)

Country Link
US (1) US5998406A (enExample)
EP (1) EP1030852B1 (enExample)
JP (1) JP2001522849A (enExample)
KR (1) KR20010031953A (enExample)
CN (1) CN1154644C (enExample)
AT (1) ATE250054T1 (enExample)
AU (1) AU739055B2 (enExample)
BR (1) BR9813985A (enExample)
CA (1) CA2303959A1 (enExample)
DE (1) DE69818294T2 (enExample)
DK (1) DK1030852T3 (enExample)
ES (1) ES2207010T3 (enExample)
HU (1) HUP0100470A3 (enExample)
IL (1) IL136062A (enExample)
NO (1) NO317291B1 (enExample)
NZ (1) NZ504503A (enExample)
PT (1) PT1030852E (enExample)
RU (1) RU2215740C2 (enExample)
SK (1) SK284577B6 (enExample)
TR (1) TR200001330T2 (enExample)
WO (1) WO1999024428A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA06002188A (es) * 2003-08-25 2006-04-27 Warner Lambert Co Nuevos compuestos antimicrobianos de ariloxazolidinona.
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
CA2610978A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
EP2669283A1 (en) 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinone derivative having 7-membered hetero ring
US20130296569A1 (en) 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ES2157934T3 (es) * 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
PT1030852E (pt) 2004-02-27
NO20002434L (no) 2000-05-11
CN1271358A (zh) 2000-10-25
KR20010031953A (ko) 2001-04-16
CA2303959A1 (en) 1999-05-20
DE69818294D1 (de) 2003-10-23
ATE250054T1 (de) 2003-10-15
HUP0100470A2 (hu) 2002-05-29
JP2001522849A (ja) 2001-11-20
WO1999024428A1 (en) 1999-05-20
SK6182000A3 (en) 2000-12-11
EP1030852A1 (en) 2000-08-30
EP1030852B1 (en) 2003-09-17
TR200001330T2 (tr) 2000-11-21
NO317291B1 (no) 2004-10-04
RU2215740C2 (ru) 2003-11-10
AU739055B2 (en) 2001-10-04
DK1030852T3 (da) 2003-12-22
NO20002434D0 (no) 2000-05-11
DE69818294T2 (de) 2004-07-08
ES2207010T3 (es) 2004-05-16
SK284577B6 (sk) 2005-07-01
IL136062A (en) 2004-02-08
IL136062A0 (en) 2001-05-20
HK1030373A1 (en) 2001-05-04
CN1154644C (zh) 2004-06-23
NZ504503A (en) 2002-10-25
HUP0100470A3 (en) 2002-08-28
AU1277899A (en) 1999-05-31
US5998406A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
PT1030852E (pt) Derivados de oxazolidinona e composicoes farmaceuticas
ATE239376T1 (de) Antimikrobielle zusammensetzung.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DE69625122D1 (de) Orale antibakterielle Zusammensetzung zum Aufbringen auf Zahnimplantatoberflächen
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
BR9807234A (pt) Composição farmacêutica
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
AR028706A1 (es) Tiazina oxazolidinona
KR910009242A (ko) 치근막 질환 치료용 서방성 조성물
BR0016605A (pt) Oxazolidinonas possuindo uma funcionalidade sulfoximina e seus usos como agente antimicrobiano
BR9910443A (pt) Aperfeiçoamento da atividade de agentes antibacterianos de oxazolidinona usando-se derivados de arginina
BR0008779A (pt) Composições e métodos para tratamento de infecções estafilocócicas
AU5162396A (en) Protective agent for organ or tissue
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
BR0213372A (pt) Medicamento compreendendo combinação de derivado de traizaespiro[5,5]undecano com inibidor de citocromo p450 isozima 3a4 e/ou inibidor de glocoproteìna-p
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
DE60005517D1 (de) Kaliumkanal-blockierende mittel
NZ293691A (en) Use of a medicament containing an anilide compound for treatment of type i allergic diseases
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
GB2370486A (en) Ingestible compositions comprising antibacterial agents
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: ESCLARECA O DEPOSITANTE A DIVERGENCIA EXISTENTE ENTRE O NOME DO INVENTOR JACKSON B. HESTER, JR.(US), CONSTANTE DA PUBLICACAO WO 99/24428 DE 20/05/99, E O DO DOCUMENTO DE PRIORIDADE AMERICANO US 60/065.376 DE 12/11/97, APRESENTADO JUNTO A PETICAO DE ENTRADA DA FASE NACIONAL.

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 11A, 12A, 13A, 14A E 15A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA.